Commonwealth Credit Partners BDC I, Inc.
Other · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $30.0M | $45.9M | $47.1M | $9.4M | $669,000 |
| Total assets | $662.7M | $658.0M | $630.4M | $366.2M | $253.5M |
| Total liabilities | $104.3M | $114.2M | $103.8M | $1.7M | $113.4M |
| Equity | $558.4M | $543.8M | $526.7M | $364.5M | $0 |
| EPS (diluted) | $50.44 | $80.94 | $97.70 | $46.22 | $19.70 |
| Shares out. | 582,249 | 547,439 | 460,850 | 373,705 | 140,620 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 5.4%
- Return on assets
- 4.5%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 15.7%
- Debt / equity
- 0.19×
- Book value / share
- $958.96
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −34.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 0.5%clean
- Piotroski F-Score
- 3/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 good- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Uaw Retiree Medical Benefits TrustActivist (13D)Jul 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Uaw Chrysler Retirees Medical Benefits Plan10% owner | Jul 8, 2025 | Buy | 6,253.39 | $926.13 |
| Uaw Chrysler Retirees Medical Benefits Plan10% owner | Jun 21, 2023 | Buy | 5,945.32 | $974.12 |
| Uaw Chrysler Retirees Medical Benefits Plan10% owner | Feb 24, 2023 | Buy | 16,823.14 | $975.39 |
| Uaw Chrysler Retireees Medical Benefits Plan10% owner | Dec 20, 2022 | Buy | 19,402.45 | $994.97 |
| Uaw Chrysler Retireees Medical Benefits Plan10% owner | Oct 19, 2022 | Buy | 5,820.73 | $994.97 |
| Uaw Chrysler Retireees Medical Benefits Plan10% owner | Aug 11, 2022 | Buy | 4,838.21 | $997.52 |
| Uaw Chrysler Retireees Medical Benefits Plan10% owner | May 6, 2022 | Buy | 11,562.1 | $1001.80 |
| Uaw Chrysler Retireees Medical Benefits Plan10% owner | Dec 23, 2021 | Buy | 17,494.03 | $993.16 |
| Uaw Chrysler Retireees Medical Benefits Plan10% owner | Sep 28, 2021 | Buy | 3,860.97 | $1000.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Other material eventNov 7, 2025
- Shareholder voteSep 25, 2025
- Other material eventAug 11, 2025
- Unregistered equity saleAug 4, 2025
- Shareholder voteMay 30, 2025
- Director / officer changeApr 12, 2024
- Entered a material agreement · Shareholder voteJul 5, 2023
- Unregistered equity saleJun 26, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QMay 12, 2026
- 10-KMar 12, 2026
- 10-QNov 12, 2025
- 8-KNov 7, 2025
- 40-17GOct 2, 2025
- 8-KSep 25, 2025
- DEF 14ASep 5, 2025
- PRE 14AAug 27, 2025
- 10-QAug 13, 2025
- 8-KAug 11, 2025
- 8-KAug 4, 2025
- 4OWNERSHIP DOCUMENTJul 10, 2025
- SCHEDULE 13D/AJul 10, 2025
- SCHEDULE 13D/AJul 2, 2025
- 40-APP/AJun 3, 2025